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Lymphangiogenesisa b s t r a c t
Prox1 encodes a homeobox transcription factor critical to organ development, but its regulation is
poorly understood. Here, we show that Prox1 expression is induced by hypoxia, and controlled by a
hypoxia-response element (HRE) at the Prox1 promoter/regulatory region and HIF-1a/HIF-2a. EMSA
and ChIP assays demonstrated the direct interaction of the HRE with HIF-1a or HIF-2a. Overexpres-
sion of HIF-1a or HIF-2a increased activation of the Prox1 promoter, whereas knockdown of HIF-1a
or HIF-2a inhibited the activation. These data reveal a novel molecular mechanism for regulation of
Prox1 expression in response to hypoxia and provide new insights into Prox1-controlled processes
such as lymphangiogenesis.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The Prox1 gene encodes a homeobox transcription factor that
plays an important role in organ development during embryogen-
esis [1]. The human Prox1 gene is located on chromosome 1q32.2–
q32.3 and composed of 5 exons and 4 introns [2]. The Prox1
transcription factor contains 737 amino acid residues and has an
estimated molecular weight of 82.3 kDa [2]. Structurally, Prox1
contains a nuclear localization signal (NLS) and two nuclear recep-
tor boxes (NR Box) at the N-terminus, and an atypical homeodo-
main followed by a prospero domain at the C-terminus [3]. The
homeobox and prospero domain are responsible for DNA binding
and the NR boxes can interact with nuclear receptors such as
HNF4a/NR1A1, LRH-1/NR5A2 (FTF) and SF-1/NR5A1 [4]. The pros-
pero domain contains a PCNA interacting protein motif [5]. The
transcriptional activation domain of Prox1 has not been identiﬁed
yet.
Prox1 is critical to embryonic morphogenesis and development
[1] as Prox1 knockout mice die at E15 before birth [6]. Prox1 is best
known as a marker for monitoring the development of the lympha-
tic vasculature in various tissues [7,8]. Prox1 knockout embryoslacked the lymphatic vasculature although vasculogenesis and
angiogenesis were not affected in these embryos, suggesting that
it is required speciﬁcally for the development of the lymphatic sys-
tem [3,6,7]. Dudas et al. showed that Prox1 was a hepatocyte mar-
ker during liver development, and the liver was 70% smaller in
Prox1 knockout embryos than in their wild type counterparts due
to lack of hepatocytes [4,9–12]. Prox1 was also involved in the
development of the heart. Mice with cardiac-speciﬁc knockout of
Prox1 had 30% reduction in the size of the heart [13]. In addition,
Prox1 has been shown to be critical to the development of the pan-
creas, lens, spinal cord, and the central nervous system [11,14–16].
Despite the importance of Prox1 as a key regulatory protein crit-
ical to the development of various organs, little is known about
how Prox1 expression is regulated. Hypoxia is an important phys-
iological stimulus often associated with a variety of pathological
states [17]. HIF-1a and HIF-2a are the pivotal mediators of the cel-
lular responses to hypoxia, and play major roles in development,
physiology and pathophysiology [18–20]. The HIF transcription
factors are basic helix-loop-helix-PER-ARNT-SIM (bHLH-PAS) pro-
teins that form heterodimeric complexes composed of an O2-labile
a-subunit (e.g. HIF-1a, HIF-2a) and a stable b-subunit (HIF-1b)
[18]. These subunits bind hypoxia-responsive elements (HREs) that
contain a conserved RCGTG core sequence. HIF-1a and HIF-2a sub-
units are structurally similar in their DNA binding and dimeriza-
tion domains, but differ in their transactivation domains [21].
Here, we show that hypoxia can induce the expression of Prox1
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scriptional level.
2. Materials and methods
2.1. Plasmids and siRNAs
Using human genomic DNA, we ampliﬁed the proximal pro-
moter region of Prox1 (1500 to +300 ﬂanking the transcription
start site, TSS) that contains a consensus DNA binding site for
HIF-1a/HIF-2a (HRE) by PCR analysis. The PCR primers included
a forward primer of 50-GCGCGCGGTACCCCAGATGTTTGCAACATA-
TA-30 and a reverse primer of 50-GCGCGCCTCGAGGCAGGAGAAA-
GAAGGAAAGG-30. The PCR product was digested with restriction
enzymes KpnI and XhoI and sub-cloned into the multiple cloning
site of the pGL3-basic luciferase vector cut with the same enzymes.
In this construct, the Prox1 promoter fragment was inserted up-
stream of the ﬁreﬂy luciferase coding region. Then, the HRE se-
quence was mutated from ACGTG into ACATA using PCR-based
site-directed mutagenesis as described previously [22]. The prim-
ers used for mutagenesis included a forward primer 50-
TGTGACATACAGTCTTCCTGTT-30, a reverse primer of 50-CTGTAT-
GTCACATCCTTCAGCT-30, and the two PCR primers described above.
The two resulting plasmids were referred to as WT-Prox1p-Luc and
MUT-Prox1p-Luc, respectively.
Information on other plasmids and siRNAs can be found in on-
line Supplementary information.
2.2. Luciferase assays
Luciferase assays were carried out as described previously by us
[22,23]. Each experiment was performed in triplicate and repeated
at least three times. Details are in online Supplementary
information.
2.3. Hypoxia treatment
Hypoxic conditions were induced by culturing the cells in a
standard hypoxic exposure condition with 3% O2, 5% CO2, and
92% N2 in a hypoxic incubator (Heal Force, HF100, Shanghai, China)
for 48 h. Hypoxic conditions were also mimicked by adding to cul-
ture media 100 lM of hypoxia-mimetic agents desferrioxamine
(DFX, Sigma–Aldrich, Hamburg, Germany), cobalt (II) chloride
(CoCl2, Sigma–Aldrich, Hamburg, Germany) or dimethyloxalylgly-
cine (DMOG, Sigma–Aldrich, Hamburg, Germany) [24,25]. The cells
were then incubated for 48 h under a normoxic condition (5% CO2,
21% O2, and balance N2) in a humidiﬁed incubator (Forma scien-
tiﬁc, Marietta, OH, USA).
2.4. Real-time PCR analysis
Real time quantitative PCR analysis was carried out as described
previously [23]. Details are in online Supplementary information.
2.5. Western blot analysis
Western blot analysis was carried out as described by us previ-
ously [26]. Details are in online Supplementary information.
2.6. Electrophoretic mobility shift assays (EMSA) for detecting protein–
DNA interaction
EMSA were carried out using a LightShift chemiluminescent
EMSA kit (catalog #20148; Thermo Scientiﬁc, Rockford, IL, USA)
as described [27]. Details are in online Supplementary information.2.7. Chromatin immunoprecipitation (ChIP) assays
ChIP assays were performed using the EZ-ChIP kit (Millipore,
Billerica, MA, USA) as described [28]. ChIP assays were replicated
three times. Details are in online Supplementary information.
2.8. Statistical analysis
The data were from three independent experiments, and pre-
sented as means ± standard deviation (S.D.). Statistical analysis
was carried out with a Student’s t-test using SPSS version 16.0 soft-
ware (SPSS, Chicago, IL, USA). Differences were considered statisti-
cally signiﬁcant when P < 0.05.
3. Results
3.1. Identiﬁcation of a highly conserved hypoxia-response element
(HRE) at the Prox1 promoter and regulatory region
To characterize the critical role of Prox1 in lymphangiogenesis
and development of other organs, we analyzed potential molecular
mechanisms that regulate the expression of Prox1 by focusing
on its promoter and regulatory region. From DBTSS (Database
of Transcriptional Start Sites, http://dbtss.hgc.jp/index.html?
nmid=DBTSS:NM_002763), we identiﬁed the transcriptional start
site (TSS) of Prox1 at the physical position of 214,161,859 on human
chromosome 1. The sequence for the Prox1 promoter and regulatory
region was retrieved from the TRED database (http://rulai.cshl.edu/
cgi-bin/TRED/tred.cgi?process=promInfo&pid=1871), and used for
identifying DNA sequence motifs that bind to transcription factors
using PROMO 3.0 and Contra V2. A Position Weight Matrix
(PWM) for HIF-1a/HIF-2a was selected from the TRANSFAC collec-
tion and used for the analysis (Fig. 1A). The analysis led to the iden-
tiﬁcation of an HRE for HIF-1a/HIF-2a located at 640 bp to
592 bp upstream of the Prox1 TSS (Fig. 1B). Further analysis
showed that the HREwas highly conserved among different species
during evolution (Fig. 1B).
3.2. Hypoxia induces transcriptional activation of the Prox1 promoter
To test whether the HRE in the Prox1 promoter/regulatory re-
gion is functional, we constructed a WT-Prox1p-Luc reporter gene
in which a Prox1 promoter/regulatory fragment (1500 to +300 bp
from TSS) was cloned upstream of the luciferase gene (Luc)
(Fig. 2A). HeLa cells were transfected with the reporter, cultured
under a normoxic condition or a hypoxic condition, and assayed
for transcriptional activation of the Prox1 promoter as represented
by luciferase activity. As shown in Fig. 2B, hypoxia-mimetic agents
CoCl2, DFX and DMOG all increased the Prox1 promoter activity by
2.5-fold compared to control PBS. Incubation of the transfected
cells at a hypoxia chamber (3% O2) increased the Prox1 promoter
activity by about threefold compared to under a normal culture
condition (normoxia, 21% O2) (Fig. 2C).
To determine whether the HRE is responsible for hypoxia-in-
duced transactivation of the Prox1 promoter, we mutagenized the
HRE from ACGTG to ACATA in WT-Prox1p-Luc. The mutation abol-
ished the response of the Prox1 promoter to hypoxia (Fig. 2B and
C). These results suggest that the HRE at the Prox1 promoter/regu-
latory region is directly involved in regulating the transcriptional
initiation of the Prox1 gene.
3.3. Hypoxia induces up-regulation of Prox1 expression in vivo
To further validate the ﬁnding that hypoxia induces Prox1
expression, we investigated whether the expression levels of
Fig. 1. Identiﬁcation of a highly conserved HIF-1a/HIF-2a binding site (HRE) in the Prox1 promoter region in different species by bioinformatic analysis. (A) A PositionWeight
Matrix (PWM) used for identifying HREs from the TRANSFAC collection. (B) A consensus HRE for HIF-1a/HIF-2a-binding was identiﬁed in the region 640 bp to 592 bp
upstream of the transcription start site (TSS) at the proximal promoter of human Prox1 gene. The sequence for the chromosome 1 region from 214,161,219 to 214,161,268 of
the human Prox1 promoter is shown and the HIF binding site is highlighted. The HREs at the Prox1 promoters show high conservation among different species. The TSS is at
the position of 214,161,859.
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oxic conditions. We selected four cell lines for this study, includ-
ing human umbilical endothelial cells (HUVEC) in which Prox1
was highly expressed, SY-SY5Y representing the neuronal system,
HLE representing the lens system, and HepG2 representing the li-
ver system. Endogenous Prox1 expression was easily detected in
all four cell lines (data not shown). The cells were incubated at
either a normoxic condition or a hypoxic condition for 48 h,
and then used for measuring the expression levels of Prox1 mRNAor protein. Real-time PCR analysis showed that Prox1 mRNA
expression was dramatically increased by hypoxia (5- to 13-
folds) in all four cell lines tested (Fig. 3A–D). By comparison,
the magnitude of induction of positive control VEGF-A mRNA
expression was considerably less than that for Prox1 mRNA
expression (Fig. 3A–D). On the protein level, Western blot analy-
sis showed that the expression of Prox1 was markedly increased
in response to hypoxia as compared to normoxia in all four cell
lines (Fig. 3E–H).
Fig. 2. Hypoxia signiﬁcantly induces transcriptional activation of the human Prox1 promoter. (A) Schematic diagram of the Prox1 promoter luciferase reporter genes (Prox1p-
Luc). WT, wild type Prox1p-Luc reporter; MUT, mutant Prox1p-Luc with the HRE sequence mutated from ACGTG to ACATA. (B) Transcriptional activation activity (i.e. relative
luciferase activity) for WT or MUT Prox1p-Luc reporters in HeLa cells treated with PBS buffer (negative control) or hypoxic mimetic reagents DFX, CoCl2 or DMOG for 48 h. (C)
Transcriptional activation activity (i.e. relative luciferase activity) of WT or MUT Prox1p-Luc reporters in HeLa cells cultured under a normal condition (Normoxia) or in a
hypoxic incubator (3% O2, Hypoxia) for 48 h.
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both HIF-1a and HIF-2a
HIF-1a and HIF-2a are the two transcriptional factors that
mediate the cellular responses to hypoxia. Therefore, we hypothe-
sized that HIF-1a, HIF-2a, or both are involved in the transactiva-
tion of the Prox1 promoter under hypoxia. To test the hypothesis,
we co-transfected WT-Prox1p-Luc and a HIF-1a mammalian
expression plasmid or a HIF-2a expression plasmid into HeLa cells
and performed dual luciferase assays. As shown in Fig. 4A, overex-
pression of either HIF-1a or HIF-2a signiﬁcantly increased the
Prox1 promoter activity compared to the empty vector control.
We also investigated whether the expression of endogenous
Prox1 mRNA in HLE cells was affected by overexpression of HIF-
1a or HIF-2a by real-time qPCR and Western blot analyses. The
expression level of endogenous Prox1mRNA increased signiﬁcantly
with overexpression of HIF-1a or HIF-2a (Fig. 4B). The Prox1mRNA
expression appeared to be more responsive to HIF-2a than to HIF-
1a (Fig. 4B). Western blot analysis showed that successful overex-
pression of either HIF-1a or HIF-2a also increased the expression
level of Prox1 protein compared to the vector control (Fig. 4C).
To further validate the above ﬁnding that both HIF-1a and HIF-
2a mediate the induced transcriptional activation of Prox1, we
knocked down expression of HIF-1a and HIF-2a by speciﬁc siRNAs
in HLE cells and incubated the cells under in a hypoxia chamber (a
condition with increased HIF-1a or HIF-2a) for 48 h. The expres-
sion level of Prox1 was quantiﬁed by Western blot analysis. As
shown in Fig. 4D, HIF-1a or HIF-2a expression was successfully
knocked down by their respective siRNA compared to a universal
scramble siRNA (Fig. 4D). Prox1 protein expression under hypoxia
was down-regulated by either HIF-1a or HIF-2a siRNA. Knockdownof both HIF-1a and HIF-2a reduced Prox1 protein expression much
more than knockdown of either one (Fig. 4D).
3.5. HIF-1a or HIF-2a interacts directly with the HRE at the Prox1
promoter
To further explore the molecular mechanism by which hypoxia
induces expression of Prox1, we performed EMSA using a biotin-la-
beled, double-stranded oligonucleotide probe containing the Prox1
HRE located at the region of 640 bp to 592 bp upstream from
the TSS (Fig. 5A). Incubation of the EMSA probe with proteins ex-
tracts isolated from HLE cells transfected with either HIF-1a or
HIF-2a expression plasmids resulted in a protein–DNA complex
formation (Fig. 5B, lane 2 and lane 4). The protein–DNA complex
formation disappeared with addition of 200-fold excess of an unla-
beled competitor, a double-stranded oligonucleotide probe con-
taining the consensus HRE sequence (Fig. 5A and B, lane 3 and
lane 5). The protein–DNA complex was speciﬁc to either HIF-1a
or HIF-2a because it disappeared when protein extracts were
pre-incubated with an anti-HIF-1a or anti-HIF-2a antibody in
EMSA and a super-shifted protein–DNA complex was observed
(Fig. 5B, lane 6 and lane 7). These data suggest that the Prox1
HRE can interact directly with either HIF-1a or HIF-2a in vitro.
The in vitro EMSA results were validated by ChIP analysis using
HLE cells treated with hypoxia, which demonstrated that endoge-
nous, native HIF-1a or HIF-2a could bind to the Prox1 promoter
in vivo (Fig. 6). The protein–DNA complex between the Prox1
HRE and HIF-1a or HIF-2a in HLE cells was immunoprecipitated
using an antibody speciﬁcally against HIF-1a or HIF-2a or anti-rab-
bit IgG as negative control. The identity of the DNA in immunopre-
cipitates was identiﬁed by real-time PCR analysis using primers
Fig. 3. Hypoxia induces expression of endogenous Prox1 in four different cell lines, HUVEC, SY-SY5Y, HLE and HepG2. (A–D) Hypoxia dramatically stimulated expression of
Prox1mRNA. HUVEC, SY-SY5Y, HLE and HepG2 cells were cultured under either normoxic or hypoxic conditions (3% O2) for 48 h and then used for measuring the expression
level of Prox1mRNA by real-time PCR analysis. The VEGF-A gene was used as a positive control. (E–H) Hypoxia stimulated expression of Prox1 protein. Cells were treated as in
A–D for 48 h, lysed and used for Western blot analysis to measure the expression level of Prox1 protein. Tubulin was used as the loading control. The relative intensity of the
Prox1 band over that of the tubulin band was noted in brackets above the Western blot image.
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of the Prox1 HRE with either an anti-HIF-1a antibody or an
anti-HIF-2a antibody, but not with control rabbit IgG (Fig. 6B).
By contrast, real-time PCR analysis did not detect any PCR signal
in a distal Prox1 region without HRE (Fig. 6B). These data indicate
that HIF-1a or HIF-2a can interact with the Prox1 HRE in vivo.
4. Discussion
In this study, we characterized the regulatory mechanisms for
the expression of the homeobox gene Prox1. We found that Prox1
expression was dramatically increased under hypoxia. The hypox-
ia-response of Prox1 was mediated by HIF-1a and HIF-2a, which
are two pivotal mediators for cellular responses to hypoxia and
play major roles in development, physiology and pathophysiology.
Bioinformatic analysis identiﬁed one potential HRE for HIF-1a and
HIF-2a at the promoter region of Prox1 (Fig. 1). Luciferase assays
using a Prox1 promoter reporter showed that hypoxia induced
transcriptional activation of the Prox1 promoter. A HRE mutation
from ACGTG to ACATA abolished the transcriptional activation of
Prox1 by hypoxia, suggesting that the HRE is essential for the acti-
vation (Fig. 2). Both EMSA and ChIP assays showed that HIF-1a and
HIF-2a interacted with the HRE within the Prox1 proximal pro-
moter region (Figs. 5 and 6). Hypoxia dramatically increased Prox1
expression at both the mRNA and protein levels (Fig. 3). In addi-
tion, Prox1 expression was induced by overexpression of either
HIF-1a or HIF-2a. Depletion of HIF-1a and HIF-2a abolished theinduction of Prox1 transcription under hypoxia (Fig. 4). These stud-
ies indicate that Prox1 expression is regulated by hypoxia, HIF-1a
and HIF-2a.
The regulation of Prox1 is an area less well-characterized. In
2011, two independent studies started to shed some insights into
the potential upstream regulators of Prox1 in the neuronal system.
In one study, the expression level of Prox1 was increased in neuro-
nal progenitor cells by twofold in SOX1 knockout mice [29]. The
study suggests that SOX1 may regulate the expression of Prox1,
but the molecular mechanism is not known, nor is whether the
regulation is direct or indirect. In the second study, Prox1 regula-
tion was found to be positively regulated by two TCF/LEF sites in
the Prox1 regulatory region upon activation of the Wnt signaling
pathway in the adult hippocampus [30]. The ﬁnding of direct tran-
scriptional regulation of Prox1 by HIF-1a and HIF-2a in the present
study signiﬁcantly expands the spectrum of upstream regulators of
Prox1 and provides novel insights into the regulatory mechanisms
for Prox1 transcriptional activation.
HIF-1a and HIF-2a are structurally and functionally similar, but
not identical. They can modulate the transcriptional activation of a
set of common genes, but each can regulate a distinct set of target
genes [31]. Previously studies showed that the N-terminal activa-
tion domain (NAD) contributes to the target gene speciﬁcity by
HIF-1a and HIF-2a, whereas the C-terminal activation domain
(CAD) activates common target genes [18,31]. In the present study,
we found that both HIF-1a and HIF-2a can individually activate
Prox1 expression (Fig. 4A–C). HIF-2a appeared to be a consistently
Fig. 4. Transcriptional activation of Prox1 is regulated by both HIF1a and HIF2a. (A) Overexpression of HIF-1a or HIF-2a by transient transfection in HeLa cells for 48 h
increased transcriptional activation activity (i.e. relative luciferase activity) of WT Prox1p-Luc reporter. Transfection with an empty vector was used as control. (B)
Overexpression of HIF-1a or HIF-2a by transient transfection in HLE cells for 48 h increased the expression level of Prox1 mRNA as measured by real-time PCR analysis.
Transfection with an empty vector was used as control. (C) Overexpression of HIF-1a or HIF-2a by transient transfection in HLE cells for 48 h increased the expression level of
Prox1 protein as measured by Western blot analysis. The expression level of HIF-1a or HIF-2a was also measured by Western blot analysis. Tubulin was used as the loading
control. The relative intensity of the Prox1 band over that of the tubulin band was noted in brackets above the Western blot image. The experiments were performed under
the normoxic conditions. (D) Knockdown of expression of HIF-1a and/or HIF-2a decreased the expression level of Prox1 protein. HLE cells cultured under hypoxic conditions
(3% O2) were transfected with HIF-1a siRNAs (siHIF1A), HIF-2a siRNAs (siHIF2A) or both siRNAs for 48 h, lysed and used for Western blot analysis to measure the expression
levels of Prox1, HIF-1a and HIF-2a. sicontrol, universal scramble control siRNA. Tubulin was used as the loading control. The relative intensity of the Prox1 band over that of
the tubulin band was noted in brackets above the Western blot image.
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were signiﬁcant in the real-time PCR analysis only (P < 0.001,
Fig. 4B), but not in the luciferase assays or Western blot analysis
(p = 0.51 in Fig. 4A, p = 0.27 in Fig. 4C). In the RNA interference
studies, a marked decrease of Prox1 expression was observed only
when both HIF-1a and HIF-2a were knocked down (Fig. 4D), con-
sistent with the ﬁnding that either HIF-1a or HIF-2a can activate
Prox1 expression (redundancy). Thus, HIF-1a and HIF-2a may
mediate transcriptional activation of Prox1 using the CAD. More-
over, expression of HIF-1a was more ubiquitous than HIF-2a.
HIF-2a expression showed tissue-speciﬁcity, and is expressed onlyin certain tissues such as the endothelium, kidney, lung, heart, and
small intestine [32]. Therefore, expression of Prox1 may show tis-
sue-speciﬁc patterns under hypoxia, and future studies are needed
to test this hypothesis.
Prox1playsanessential role in lymphangiogenesis [33]. Although
it is well-known that hypoxia and its effectors HIF-1a and HIF-2a
can induceangiogenesis [18], its role in lymphangiogenesis is largely
uncertain. Our results showing strong induction of Prox1mRNA and
proteinbyhypoxiaprovideadditional evidence thathypoxiamay in-
deed promote lymphangiogenesis by activating Prox1. Recently, hy-
poxia was shown to inﬂuence lymphangiogenesis in the presence of
Fig. 5. HIF-1a and HIF-2a interacts with the HRE at the Prox1 promoter in vitro. (A)
Sequences of a biotin-labeled double strand oligonucleotide probe containing the
Prox1 HRE used for EMSA and an unlabeled oligonucleotide probe with the HIF-1a
consensus binding sequence used as a competitor in EMSA. (B) EMSA. Nuclear
extracts from HLE cells transfected with a HIF-1a or HIF-2a expression plasmid
were incubated with the biotin-labeled EMSA probe for 20 min, and fractionated
through a 5% polyacrylamide gel. The DNA–protein complex was detected by
chemiluminescence. Nuclear extracts containing HIF-1a or HIF-2a resulted in
formation of a DNA–protein complex (lane 2 and lane 4 in comparison to lane 1
without nuclear extracts). The HIF-1a-DNA or HIF-2a-DNA complex was eliminated
by addition of 200-fold excess of the EMSA competitor (lane 3 and lane 5). The HIF-
1a-DNA complex and HIF-2a-DNA complex can be shifted by a speciﬁc anti-HIF-1a
antibody (lane 6) and an anti-HIF-2a antibody (lane 7). SS complex, super-shifted
protein-DNA complex.
Fig. 6. HIF-1a and HIF-2a interacts with the HRE at the Prox1 promoter in vivo. (A)
Schematic diagram of the 50-upstream region of the human Prox1 gene. TSS denotes
the transcription start site (+1 position). A pair of qPCR primers covering a proximal
region containing the Prox1 HRE (640 bp to 592 bp) was used for ChIP analysis. A
pair of qPCR primers covering a distal region, about 6000 bp upstream from TSS was
used as a negative control for ChIP analysis. (B) ChIP analysis indicates that both
HIF-1a and HIF-2a could bind speciﬁcally to the Prox1 HRE in the proximal
promoter region, but not to the distal site without an HRE. Immunoprecipitation
was preformed with an anti-HIF-1a antibody or an anti-HIF-2a antibody, whereas
IgG was used as control. (⁄⁄⁄P < 0.0001 compared to IgG; #not signiﬁcant compared
to IgG).
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1awas shown to correlatewith expression of VEGF-C and lymphan-
giogenesis during wound healing, in response to inﬂammation, and
in breast cancer [35,36]. Activation of the tyrosine kinase-linked
receptor VEGFR3 has been shown to drive lymphangiogenesis in-
ducedbyVEGF-C [37]. Flister et al. [33] showedthatNF-kBandProx1
can coordinately up-regulates expression of VEGFR3. Here, we iden-
tiﬁed Prox1 as a direct target forHIF-1a andHIF-2a.Wepropose that
hypoxia induces transcriptional activation of Prox1 by HIF-1a and
HIF-2a, which up-regulates the expression of VEGFR3, facilitating
lymphangiogenesis. Our study may, therefore, provide on potential
mechanism by which hypoxia promotes lymphangiogenesis.
Prox1 expression has been shown to be increased in several
primary cancers, including colon cancer, brain tumors (astrocytic
gliomas) and Kaposi sarcoma [1]. Because the tumor microenviron-
ment is highly hypoxic, up-regulation of Prox1 in cancers noted
above may be through the hypoxia-response mechanism identiﬁed
in this study for Prox1. In addition, Prox1 has been shown to be
involved in the development of the central nervous system, lens,liver, pancreas, and heart [1,30]. Moreover, one major pathway
for cancer metastasis is through lymphatic vessels [38]. It should
be interesting to investigate the potential role of hypoxia-induced
Prox1 expression in these physiological and pathological processes
in the future.
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